GHRH analog.
Stimulates GH release with strong specificity for visceral adipose tissue reduction.
Use
Visceral fat reduction, particularly trunk. Cognitive support in older populations.
Route
Subcutaneous injection, daily.
Pairs with
Ipamorelin. CJC-1295. GLP-1 if also targeting subcutaneous fat.
Status
FDA-approved for HIV-associated lipodystrophy. Used off-label for visceral fat.